Elicio Therapeutics, Inc. (ELTX)
13.55
+0.95
(+7.54%)
USD |
NASDAQ |
Apr 17, 16:00
13.48
-0.07
(-0.52%)
Pre-Market: 20:00
Elicio Therapeutics Cash from Investing (Quarterly) : -0.016M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Aura Biosciences, Inc. | 29.82M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Alnylam Pharmaceuticals, Inc. | -37.17M |
| Savara, Inc. | -93.56M |
| BioMarin Pharmaceutical, Inc. | -42.45M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.797M |
| Cash from Financing (Quarterly) | 4.863M |
| Free Cash Flow | -36.97M |
| Free Cash Flow Per Share (Quarterly) | -0.3827 |
| Free Cash Flow to Equity (Quarterly) | -6.268M |
| Free Cash Flow to Firm (Quarterly) | -6.476M |
| Free Cash Flow Yield | -17.19% |